Application of physiologically based pharmacokinetic modeling in setting acute exposure guideline levels for methylene chloride.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
TitleApplication of physiologically based pharmacokinetic modeling in setting acute exposure guideline levels for methylene chloride.
PubliekssamenvattingAcute exposure guideline levels (AEGLs) are derived to protect the human population from adverse health effects in case of single exposure due to an accidental release of chemicals into the atmosphere. AEGLs are set at three different levels of increasing toxicity for exposure durations ranging from 10 min to 8 h. In the AEGL setting for methylene chloride, specific additional topics had to be addressed. This included a change of relevant toxicity endpoint within the 10-min to 8-h exposure time range from central nervous system depression caused by the parent compound to formation of carboxyhemoglobin (COHb) via biotransformation to carbon monoxide. Additionally, the biotransformation of methylene chloride includes both a saturable step as well as genetic polymorphism of the glutathione transferase involved. Physiologically based pharmacokinetic modeling was considered to be the appropriate tool to address all these topics in an adequate way. Two available PBPK models were combined and extended with additional algorithms for the estimation of the maximum COHb levels. The model was validated and verified with data obtained from volunteer studies. It was concluded that all the mentioned topics could be adequately accounted for by the PBPK model. The AEGL values as calculated with the model were substantiated by experimental data with volunteers and are concluded to be practically applicable.
- The Acute Exposure Guideline Level (AEGL) program: applications of physiologically based pharmacokinetic modeling.
- Authors: Bruckner JV, Keys DA, Fisher JW
- Issue date: 2004 Apr 23-May 28
- Duration adjustment of acute exposure guideline level values for trichloroethylene using a physiologically-based pharmacokinetic model.
- Authors: Boyes WK, Evans MV, Eklund C, Janssen P, Simmons JE
- Issue date: 2005 Jun
- Assessing the relevance of rodent data on chemical interactions for health risk assessment purposes: a case study with dichloromethane-toluene mixture.
- Authors: Pelekis M, Krishnan K
- Issue date: 1997 Feb
- Evaluation of two different metabolic hypotheses for dichloromethane toxicity using physiologically based pharmacokinetic modeling for in vivo inhalation gas uptake data exposure in female B6C3F1 mice.
- Authors: Evans MV, Caldwell JC
- Issue date: 2010 May 1
- Adjusting exposure limits for long and short exposure periods using a physiological pharmacokinetic model.
- Authors: Andersen ME, MacNaughton MG, Clewell HJ 3rd, Paustenbach DJ
- Issue date: 1987 Apr